Fexofenadine Hydrochloride 180 mg Tablets Under Fasting Conditions
Completed
This study will compare the relative bioavailability (rate and extent of absorption) of 180 mg Fexofenadine Hydrochloride tablets manufactured for TEVA Pharmaceuticals Industries, Ltd. with that of 180 mg ALLEGRA® Tablets by Aventis Pharmaceuticals, Inc. following a single oral dose (1 x 180 mg tablet) in healthy adult volunteers under fasting conditions.
Gender:
ALL
Ages:
Between 18 years and 55 years
Trial Updated:
08/14/2009
Locations: PRACS Institute, Ltd., Fargo, North Dakota
Conditions: Healthy
Fexofenadine Hydrochloride 180 mg Tablets Under Non-Fasting Conditions
Completed
This study will compare the relative bioavailability (rate and extent of absorption) of 180 mg Fexofenadine Hydrochloride tablets manufactured for TEVA Pharmaceuticals Industries, Ltd. with that of 180 mg ALLEGRA® Tablets by Aventis Pharmaceuticals, Inc. following a single oral dose (1 x 180 mg tablet) in healthy adult volunteers under fed conditions.
Gender:
ALL
Ages:
Between 18 years and 55 years
Trial Updated:
08/14/2009
Locations: PRACS Institute, Ltd., Fargo, North Dakota
Conditions: Healthy
Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma
Completed
The purpose of this study is to investigate the efficacy and safety of fexofenadine 120mg BID compared to placebo in the treatment of subjects with mild to moderate persistent asthma
Gender:
ALL
Ages:
Between 12 years and 80 years
Trial Updated:
08/20/2008
Locations: Aventis Pharmaceuticals Inc., Bridgewater, New Jersey +6 locations
Conditions: Asthma
Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma
Completed
The purpose of this study is to investigate the efficacy and safety of fexofenadine 120mg BID compared to placebo in the treatment of subjects with mild to moderate persistent asthma
Gender:
ALL
Ages:
Between 12 years and 80 years
Trial Updated:
08/20/2008
Locations: Aventis Pharmaceuticals Inc., Bridgewater, New Jersey +6 locations
Conditions: Asthma
Long-Term Safety Performance of Fexofenadine in Asthma
Completed
The purpose of this study is to assess the long-term safety performance of fexofenadine compared to montelukast in subjects with asthma
Gender:
ALL
Ages:
Between 12 years and 80 years
Trial Updated:
08/20/2008
Locations: Aventis Pharmaceutical Inc., Bridgewater, New Jersey
Conditions: Asthma
Post Burn Pruritus Study in Patients Undergoing Wound Healing
Completed
The purpose of this study is to see if a drug called ondansetron (Zofran) controls itching from healing burn wounds as well or better than the usual drug used, diphenhydramine (Benadryl).
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/24/2008
Locations: US Army Institute of Surgical Research, Fort Sam Houston, Texas
Conditions: Itching
Provocative Testing Using LHRH and hCG of the Pituitary-Gonadal Axis in Persons With Spinal Cord Injury.
Completed
There is evidence that has shown that serum testosterone levels are low in persons with chronic spinal cord injury (SCI). The question arises as to whether the defect in testosterone production is from the hypothalamic pituitary system (part of the brain that plays a role in testosterone release) or from the male testes. Studies to date are inconclusive. This study, will examine if persons with SCI has a normal hormonal regulation of the male hormone testosterone in comparison to persons who are... Read More
Gender:
MALE
Ages:
Between 18 years and 65 years
Trial Updated:
03/05/2008
Locations: VA Medical Center, Bronx, Bronx, New York
Conditions: Hypogonadism, Spinal Cord Injury
Health Impact Study of Aquatabs in Tamale, Ghana
Completed
The purpose of this study to determine whether Aquatabs, a water treatment tablet, reduces diarrheal diseases in a peri-urban population of Tamale, Ghana.
Gender:
ALL
Ages:
All
Trial Updated:
10/29/2007
Locations: Emory University Center for Global Safe Water, Atlanta, Georgia +2 locations
Conditions: Diarrhea